Drugs / Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A
Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00963157 | Sep 2009 → Dec 2010 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00963157 ↗ |
| Modality | Vaccine | “inactivated influenza H1N1 vaccine” NCT00963157 ↗ |
| Route | Intramuscular | “delivered intramuscularly (IM) as 3.75, 7.5, or 15 micrograms per dose” NCT00963157 ↗ |